Literature DB >> 6712299

Polymyalgia rheumatica and antimitochondrial antibodies.

M A Sattar, M I Cawley, T J Hamblin, J C Robertson.   

Abstract

Antimitochondrial antibodies (AMA) were detected in the sera of 11 of 36 patients with a clinical diagnosis of polymyalgia rheumatica (PMR) in whom comprehensive autoantibody screening had been performed. AMA did not correlate with biochemical changes of hepatic dysfunction, which are common in PMR, nor with parameters of musculoskeletal inflammation. Possible explanations are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712299      PMCID: PMC1001480          DOI: 10.1136/ard.43.2.264

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  9 in total

1.  Myalgic syndrome with constitutional effects; polymyalgia rheumatica.

Authors:  H S BARBER
Journal:  Ann Rheum Dis       Date:  1957-06       Impact factor: 19.103

2.  Raised serum-alkaline-phosphatase levels in polymyalgia rheumatica.

Authors:  E N Glick
Journal:  Lancet       Date:  1972-08-12       Impact factor: 79.321

3.  Giant-cell arteritis and raised serum-alkaline-phosphatase levels.

Authors:  G H Hall; T Hargreaves
Journal:  Lancet       Date:  1972-07-01       Impact factor: 79.321

4.  Mitochondrial antibodies and subclinical liver disease.

Authors:  J G Walker; D Doniach; I Doniach
Journal:  Q J Med       Date:  1970-01

Review 5.  [Immunologic phenomena in liver diseases: significance of mitochondrial antibodies].

Authors:  P A Berg; D Doniach; I M Roitt
Journal:  Klin Wochenschr       Date:  1969-12-15

6.  Polymyalgia rheumatica and primary biliary cirrhosis.

Authors:  J C Robertson; G F Batstone; W Y Loebl
Journal:  Br Med J       Date:  1978-10-21

7.  Ultrastructural examination of the skeletal muscles in polymyalgia rheumatica.

Authors:  R Fassbender; M Simmling-Annefeld
Journal:  J Pathol       Date:  1982-07       Impact factor: 7.996

8.  Liver involvement in polymyalgia rheumatica.

Authors:  J von Knorring; C Wassatjerna
Journal:  Scand J Rheumatol       Date:  1976       Impact factor: 3.641

9.  Is mitochondrial antibody diagnostic of primary biliary cirrhosis?

Authors:  L E Munoz; H C Thomas; P J Scheuer; D Doniach; S Sherlock
Journal:  Gut       Date:  1981-02       Impact factor: 23.059

  9 in total
  4 in total

1.  Liver scan abnormalities in polymyalgia rheumatica/giant cell arteritis.

Authors:  V Kyle; E P Wraight; B L Hazleman
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980

2.  Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study.

Authors:  B Dasgupta; O Duke; V Kyle; D G Macfarlane; B L Hazleman; G S Panayi
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

3.  High prevalence of anti-mitochondrial antibodies among patients with some well-defined connective tissue diseases.

Authors:  S Mouritsen; E Demant; H Permin; A Wiik
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

4.  Liver involvement in polymyalgia rheumatica and giant cell arteritis.

Authors:  Elvis Hysa; Alberto Castagna; Ciro Manzo
Journal:  Reumatologia       Date:  2020-12-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.